| Original language | English |
|---|---|
| Pages (from-to) | 1357-1359 |
| Number of pages | 3 |
| Journal | Archives of neurology |
| Volume | 64 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 2007 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
Medication use as a confounding factor in the use of the cerebrospinal fluid tau/β-amyloid42 ratio: Reply [4]
- Anne M. Fagan
- , Catherine M. Roe
- , Chengjie Xiong
- , Mark A. Mintun
- , John C. Morris
- , David M. Holtzman
- Department of Neurology
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Institute for Informatics, Data Science and Biostatistics (I2DB)
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Hope Center for Neurological Disorders
- Bursky Center for Human Immunology and Immunotherapy
- Center for Brain Immunology & Glia (BIG)
- DBBS - Molecular Cell Biology
- DBBS - Neurosciences
- Intellectual and Developmental Disabilities Research Center (IDDRC)
Research output: Contribution to journal › Letter › peer-review